Then come the labs elevated fasting glucose or an A1C creeping toward pre-diabetes or early type 2 diabetes
What is particularly striking is how these therapies reintroduce a physiological logic into treatment: rather than forcing insulin secretion, they restore contextmaking insulin release contingent on nutrient presence
For FDA-approved GLP-1 receptor agonists, the safety profile is well-characterized through extensive clinical trial data and post-marketing surveillance
Future trials could help elucidate other potential benefits of GLP-1 drugs beyond sugar control
Healthcare professionals are asked to report any suspected adverse reactions via email to : [email protected] By reporting side effects, you can help provide more information on the safety of this medicine
Compounded GLP-1 medications are not available in Alabama, Louisiana, or Mississippi, and branded GLP-1 medication via telehealth is limited or prohibited in Alabama or Virginia